"Unnamed: 0","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-5669034","R-HSA-5669034","TNFs bind their physiological receptors","8/135","29/10891",1.55983311583157e-09,5.80763901594028e-07,4.74644750817827e-07,"CD27/EDA2R/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF9",8
"R-HSA-5668541","R-HSA-5668541","TNFR2 non-canonical NF-kB pathway","12/135","102/10891",4.20173866611988e-09,5.80763901594028e-07,4.74644750817827e-07,"CD27/EDA2R/LTBR/TNF/TNFRSF11A/TNFRSF12A/TNFRSF14/TNFRSF1A/TNFRSF1B/TNFRSF4/TNFRSF6B/TNFRSF9",12
"R-HSA-381426","R-HSA-381426","Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)","13/135","125/10891",4.28081499946458e-09,5.80763901594028e-07,4.74644750817827e-07,"CHRDL1/CKAP4/CSF1/CST3/FGF23/FSTL3/IGFBP2/IGFBP4/IGFBP7/IL6/SHISA5/SPP1/TIMP1",13
"R-HSA-8957275","R-HSA-8957275","Post-translational protein phosphorylation","12/135","108/10891",8.14299720465616e-09,8.18656553210571e-07,6.69068849901825e-07,"CHRDL1/CKAP4/CSF1/CST3/FGF23/FSTL3/IGFBP4/IGFBP7/IL6/SHISA5/SPP1/TIMP1",12
"R-HSA-198933","R-HSA-198933","Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell","13/135","134/10891",1.00572058133977e-08,8.18656553210571e-07,6.69068849901825e-07,"B2M/CD300A/CD300E/CDH1/COLEC12/HLA-E/LAIR1/NCR3LG1/NECTIN2/NPDC1/PILRA/PILRB/VCAM1",13
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","8/135","47/10891",9.47502418768519e-08,6.42722474064645e-06,5.25282042685705e-06,"CD80/CSF1/IL10RB/IL6/TIMP1/TNF/TNFRSF1A/TNFRSF1B",8
"R-HSA-1474244","R-HSA-1474244","Extracellular matrix organization","16/135","300/10891",8.84319238461741e-07,5.14168471505612e-05,4.2021786369009e-05,"ADAM12/AGRN/CDH1/COL18A1/COL6A3/CTSL/EFEMP1/ELN/FBLN2/HSPG2/JAM2/LTBP2/SDC1/SPP1/TIMP1/VCAM1",16
"R-HSA-9694614","R-HSA-9694614","Attachment and Entry","5/135","19/10891",2.7477314856408e-06,0.000139790839331976,0.000114247782824012,"AGRN/CTSL/HAVCR1/HSPG2/SDC1",5
"R-HSA-216083","R-HSA-216083","Integrin cell surface interactions","8/135","85/10891",9.7693561284325e-06,0.000441791993808003,0.00036106626158885,"AGRN/CDH1/COL18A1/COL6A3/HSPG2/JAM2/SPP1/VCAM1",8
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","18/135","473/10891",2.08602216810939e-05,0.000849011022420523,0.00069387684749744,"CD80/CSF1/HAVCR2/IL10RB/IL15/IL18BP/IL19/IL22/IL2RA/IL4R/IL6/LGALS9/SDC1/TIMP1/TNF/TNFRSF1A/TNFRSF1B/VCAM1",18
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","17/135","482/10891",9.27506417685159e-05,0.00332982382832797,0.00272138711949215,"ADA2/B2M/B4GALT1/CD14/CD300A/CD59/CHI3L1/CKAP4/CST3/CTSZ/GM2A/LAIR1/NPC2/PIGR/PLAUR/RNASET2/TNFRSF1B",17
"R-HSA-9772572","R-HSA-9772572","Early SARS-CoV-2 Infection Events","5/135","38/10891",9.81766239310459e-05,0.00332982382832797,0.00272138711949215,"AGRN/CTSL/HAVCR1/HSPG2/SDC1",5
"R-HSA-3560782","R-HSA-3560782","Diseases associated with glycosaminoglycan metabolism","5/135","41/10891",0.000142276885577203,0.00445436095614783,0.00364044500748148,"AGRN/B4GALT1/HSPG2/OGN/SDC1",5
"R-HSA-1236977","R-HSA-1236977","Endosomal/Vacuolar pathway","3/135","11/10891",0.00028576930101035,0.00830772182222946,0.00678970670069703,"B2M/CTSL/HLA-E",3
"R-HSA-1474228","R-HSA-1474228","Degradation of the extracellular matrix","8/135","140/10891",0.000342878755950232,0.00930344357811629,0.00760348679861567,"CDH1/COL18A1/COL6A3/CTSL/ELN/HSPG2/SPP1/TIMP1",8
"R-HSA-179812","R-HSA-179812","GRB2 events in EGFR signaling","3/135","13/10891",0.00048640796068801,0.0123730025000012,0.0101121654985139,"AREG/EGFR/TGFA",3
"R-HSA-180336","R-HSA-180336","SHC1 events in EGFR signaling","3/135","14/10891",0.000613466462314557,0.0131410973769487,0.0107399114732078,"AREG/EGFR/TGFA",3
"R-HSA-3656237","R-HSA-3656237","Defective EXT2 causes exostoses 2","3/135","14/10891",0.000613466462314557,0.0131410973769487,0.0107399114732078,"AGRN/HSPG2/SDC1",3
"R-HSA-3656253","R-HSA-3656253","Defective EXT1 causes exostoses 1, TRPS2 and CHDS","3/135","14/10891",0.000613466462314557,0.0131410973769487,0.0107399114732078,"AGRN/HSPG2/SDC1",3
"R-HSA-5694530","R-HSA-5694530","Cargo concentration in the ER","4/135","33/10891",0.000699072577199193,0.0142261269460036,0.0116266807576287,"AREG/CD59/CTSZ/TGFA",4
"R-HSA-2129379","R-HSA-2129379","Molecules associated with elastic fibres","4/135","37/10891",0.0010859256611663,0.0197352474463755,0.0161291560663512,"EFEMP1/ELN/FBLN2/LTBP2",4
"R-HSA-140534","R-HSA-140534","Caspase activation via Death Receptors in the presence of ligand","3/135","17/10891",0.00111525968370181,0.0197352474463755,0.0161291560663512,"CD14/TNFRSF10A/TNFRSF10B",3
"R-HSA-180292","R-HSA-180292","GAB1 signalosome","3/135","17/10891",0.00111525968370181,0.0197352474463755,0.0161291560663512,"AREG/EGFR/TGFA",3
"R-HSA-5676594","R-HSA-5676594","TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway","3/135","18/10891",0.00132623626792517,0.0224907567102311,0.018381169327384,"LTBR/TNFRSF11A/TNFRSF12A",3
"R-HSA-3560783","R-HSA-3560783","Defective B4GALT7 causes EDS, progeroid type","3/135","20/10891",0.00181957341472432,0.0274283844367703,0.0224165769611261,"AGRN/HSPG2/SDC1",3
"R-HSA-3560801","R-HSA-3560801","Defective B3GAT3 causes JDSSDHD","3/135","20/10891",0.00181957341472432,0.0274283844367703,0.0224165769611261,"AGRN/HSPG2/SDC1",3
"R-HSA-4420332","R-HSA-4420332","Defective B3GALT6 causes EDSP2 and SEMDJL1","3/135","20/10891",0.00181957341472432,0.0274283844367703,0.0224165769611261,"AGRN/HSPG2/SDC1",3
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","7/135","143/10891",0.00198800168761728,0.0283229724370466,0.0231477028064314,"AGRN/B4GALT1/HSPG2/OGN/SDC1/SPON1/SPON2",7
"R-HSA-1566948","R-HSA-1566948","Elastic fibre formation","4/135","44/10891",0.00208768838602309,0.0283229724370466,0.0231477028064314,"EFEMP1/ELN/FBLN2/LTBP2",4
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","4/135","44/10891",0.00208768838602309,0.0283229724370466,0.0231477028064314,"HAVCR2/IL15/IL2RA/LGALS9",4
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","6/135","108/10891",0.00220943802555532,0.0290077831097102,0.0237073825492524,"IL4R/IL6/TIMP1/TNF/TNFRSF1B/VCAM1",6
"R-HSA-2024096","R-HSA-2024096","HS-GAG degradation","3/135","22/10891",0.00241395071040903,0.0307024355980149,0.025092382384515,"AGRN/HSPG2/SDC1",3
"R-HSA-2219530","R-HSA-2219530","Constitutive Signaling by Aberrant PI3K in Cancer","5/135","78/10891",0.00278105591531308,0.0342996896221947,0.0280323339470154,"AREG/CD80/EGFR/FGF23/TGFA",5
"R-HSA-449836","R-HSA-449836","Other interleukin signaling","3/135","24/10891",0.00311580402313797,0.0362323496404901,0.0296118517687698,"CSF1/IL10RB/SDC1",3
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","3/135","24/10891",0.00311580402313797,0.0362323496404901,0.0296118517687698,"AREG/EGFR/TGFA",3
"R-HSA-177929","R-HSA-177929","Signaling by EGFR","4/135","50/10891",0.00334493636223901,0.0365815401083211,0.0298972369694283,"ADAM12/AREG/EGFR/TGFA",4
"R-HSA-1793185","R-HSA-1793185","Chondroitin sulfate/dermatan sulfate metabolism","4/135","50/10891",0.00334493636223901,0.0365815401083211,0.0298972369694283,"AGRN/HSPG2/HYAL1/SDC1",4
"R-HSA-1643713","R-HSA-1643713","Signaling by EGFR in Cancer","3/135","25/10891",0.00350886634739597,0.0365815401083211,0.0298972369694283,"AREG/EGFR/TGFA",3
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","3/135","25/10891",0.00350886634739597,0.0365815401083211,0.0298972369694283,"IL10RB/IL19/IL22",3
"R-HSA-3928665","R-HSA-3928665","EPH-ephrin mediated repulsion of cells","4/135","51/10891",0.00359523735708315,0.0365815401083211,0.0298972369694283,"EFNA1/EFNA4/EPHA2/EPHB4",4
"R-HSA-1971475","R-HSA-1971475","A tetrasaccharide linker sequence is required for GAG synthesis","3/135","26/10891",0.00393091787915693,0.03902155065407,0.0318914005086929,"AGRN/HSPG2/SDC1",3
"R-HSA-5357769","R-HSA-5357769","Caspase activation via extrinsic apoptotic signalling pathway","3/135","27/10891",0.00438258552891206,0.0415674328761849,0.0339720904923689,"CD14/TNFRSF10A/TNFRSF10B",3
"R-HSA-1630316","R-HSA-1630316","Glycosaminoglycan metabolism","6/135","124/10891",0.00439164524244706,0.0415674328761849,0.0339720904923689,"AGRN/B4GALT1/HSPG2/HYAL1/OGN/SDC1",6
